Materials & Resources » Chemicals | Chem Tech Research Inc.

Chem Tech Research Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
459
126
2,516
118
4,499
Depreciation, Depletion & Amortization
632
714
813
797
1,055
Other Funds
197
100
223
797
-
Funds from Operations
1,472
1,877
607
2,062
826
Changes in Working Capital
1,998
335
1,377
2,275
1,611
Net Operating Cash Flow
526
1,542
770
213
784
Capital Expenditures
1,256
2,277
2,330
4,766
2,429
Sale of Fixed Assets & Businesses
-
-
-
6
3
Purchase/Sale of Investments
676
1,507
1,724
10,594
3,559
Net Investing Cash Flow
1,942
3,754
623
15,353
1,172
Issuance/Reduction of Debt, Net
1,795
3,852
1,271
4,738
1,145
Net Financing Cash Flow
2,317
3,783
5,058
13,910
1,145
Net Change in Cash
151
1,571
3,665
1,656
1,517
Free Cash Flow
1,639
720
3,090
4,601
3,020
Other Sources
30
30
-
-
38
Change in Capital Stock
720
31
6,105
9,968
-
Exchange Rate Effect
-
-
-
-
16
Other Uses
40
-
17
-
-

About Chem Tech Research

View Profile
Address
27 Gyeonggang-ro
Namyangju GY 12244
Korea, Republic Of
Employees -
Website http://www.c-tri.co.kr
Updated 09/14/2018
Chem Tech Research, Inc. is a holding company, which manufactures pharmaceuticals and related products based on biotechnology. The company operates through the following divisions: Pharmaceuticals, Biotechnology and Green Chemistry. Its products include peptide and antiviral drugs, ionic liquids and zanamivir derivatives.